Literature DB >> 14634546

Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean women.

Jung Gu Kim1, Jae Hee Kwon, Seok Hyun Kim, Young Min Choi, Shin Yong Moon, Jin Yong Lee.   

Abstract

OBJECTIVES: The objective of the study was to evaluate the effect of vitamin D receptor (VDR) gene haplotypes on bone mineral density (BMD). STUDY
DESIGN: The VDR Bsm I, Apa I, Taq I, and poly(A) polymorphisms were analyzed in 417 postmenopausal Korean women. Serum 1,25(OH)(2) vitamin D(3), osteocalcin, bone alkaline phosphatase, and CrossLaps were measured by immunoradiometric assay and enzyme-linked immunosorbent assay. BMD at the lumbar spine and proximal femur was determined by dual-energy x-ray absorptiometry.
RESULTS: At all skeletal sites, genotypes not carrying the baTL haplotype allele (uppercase letters signifying the absence, lowercase letters the presence, of the restriction site, and L a repeat length of more than 17) had significantly lower BMD than baTL homozygotes. The former genotypes were more prevalent in women with low bone mass than in healthy women. No significant differences in vitamin D(3) or bone markers levels were noted among the baTL haplotype genotypes.
CONCLUSION: The VDR baTL haplotype allele is related to bone mass in Korean women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634546     DOI: 10.1067/s0002-9378(03)00650-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

2.  Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women.

Authors:  Jung Gu Kim; Kyung Sil Lim; Seung-Yup Ku; Seok Hyun Kim; Young Min Choi; Shin Yong Moon
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Bone mineral density-affecting genes in Africans.

Authors:  Gordon Gong; Gleb Haynatzki; Vera Haynatzka; Ryan Howell; Sade Kosoko-Lasaki; Yun-Xin Fu; Fei Yu; John C Gallagher; M Roy Wilson
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

4.  Bone mass pharmacogenetics and ethnic health implications.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

5.  Vitamin D receptor poly(A) microsatellite and colorectal cancer risk in Caucasians.

Authors:  Jana Flügge; Gabriele Laschinski; Ivar Roots; Solveigh Krusekopf
Journal:  Int J Colorectal Dis       Date:  2008-12-04       Impact factor: 2.571

6.  Relationships between the insulin-like growth factor I (IGF-I) receptor gene G3174A polymorphism, serum IGF-I levels, and bone mineral density in postmenopausal Korean women.

Authors:  Dong Ock Lee; Byung Chul Jee; Seung-Yup Ku; Chang Suk Suh; Seok Hyun Kim; Young Min Choi; Shin Yong Moon; Jung Gu Kim
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

7.  Vitamin D receptor haplotypes protect against development of colorectal cancer.

Authors:  Jana Flügge; Solveigh Krusekopf; Mark Goldammer; Elena Osswald; Werner Terhalle; Uwe Malzahn; Ivar Roots
Journal:  Eur J Clin Pharmacol       Date:  2007-09-20       Impact factor: 2.953

8.  Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women.

Authors:  Jung Gu Kim; Hoon Kim; Byung Chul Jee; Chang Suk Suh; Young Min Choi; Shin Yong Moon
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

9.  Association between vitamin D receptor gene haplotypes and chronic periodontitis among Japanese men.

Authors:  Mariko Naito; Koichi Miyaki; Toru Naito; Ling Zhang; Keika Hoshi; Asako Hara; Katsunori Masaki; Shugo Tohyama; Masaaki Muramatsu; Nobuyuki Hamajima; Takeo Nakayama
Journal:  Int J Med Sci       Date:  2007-08-22       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.